Brought to you by 
Aushon BioSystems closes its $14mm Series B round
15 May 2009
Executive Summary
Aushon BioSystems (microarray instruments used in biomarker research) has closed its $14mm Series B venture round. The first tranche brought in $7.5mm in December 2007 and now its second raised $6.5mm from lead backer North Bridge Venture Partners (the company's sole institutional investor).
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
- Services
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com